Abstract
A series of 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5 (aggrecanase-2) is described. These compounds show microM functional inhibition of ADAMTS-5, and represent a new class of agents with the potential of inhibiting degradation of aggrecan, a major component of cartilage which is lost in osteoporosis. Compound 12 is noteworthy in that it has an ADAMTS-5 IC50: 1.1 microM and shows >40-fold functional selectivity over ADAMTS-4 (aggrecanase-1).
MeSH terms
-
ADAM Proteins / antagonists & inhibitors*
-
ADAMTS4 Protein
-
ADAMTS5 Protein
-
Aggrecans / drug effects
-
Aggrecans / metabolism
-
Cartilage
-
Humans
-
Inhibitory Concentration 50
-
Osteoporosis / drug therapy
-
Procollagen N-Endopeptidase
-
Structure-Activity Relationship
-
Thiazolidinediones / chemical synthesis*
-
Thiazolidinediones / pharmacology
Substances
-
Aggrecans
-
Thiazolidinediones
-
ADAM Proteins
-
ADAMTS5 Protein
-
ADAMTS5 protein, human
-
Procollagen N-Endopeptidase
-
ADAMTS4 Protein
-
ADAMTS4 protein, human